학술논문

Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study
Document Type
Article
Source
In The Lancet Oncology September 2015 16(9):1133-1142
Subject
Primary Research
Articles
Language
ISSN
1470-2045